Whitebox Advisors’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-34,981
Closed -$35K 910
2021
Q3
$35K Hold
34,981
﹤0.01% 527
2021
Q2
$38K Buy
+34,981
New +$30.9K ﹤0.01% 450

Whitebox Advisors's GRNAW Position: Q3 2023 in Review

Whitebox Advisors sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 32,183 shares — an estimated $428 sold.

Whitebox Advisors first reported a position in GRNAW in Q1 2021 and held it in 8 quarters. The position peaked at $42K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

  • Whitebox Advisors reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
  • Whitebox Advisors sold 32,183 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $428.
  • Whitebox Advisors first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 8 quarters.
  • Whitebox Advisors's GreenLight Biosciences Holdings, PBC Warrant position peaked at $42K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Whitebox Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.